You searched for "regulation"

3409 results found

Ripasudil after Descemet stripping in Fuch’s endothelial dystrophy

This study prospectively evaluated the use of ripasudil, a rho kinase inhibitor, in patients undergoing Descemet’s stripping only (DSO) without an endothelial graft for Fuch’s endothelial dystrophy (FED). Patients with dense central guttae limited to the central 5mm of the...

Ophthalmology elective in China

Wandering through the bustling streets of Zhejiang, China, immersed in the harmonious blend of modernity and tradition, I made my way to the Eye Centre of the Second Affiliated Hospital, Zhejiang University College of Medicine. The aroma of traditional Chinese...

Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration

This is a sub-group study of double masked review of patients randomised to different dosages and treatment frequency compared between aflibercept and ranibizumab treatment. This is to evaluate the efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with...

Progressive myelination of the retinal nerve fibre layer: Acquired or incidental?

*Co-first authors.Myelinated retinal nerve fibres are retinal nerve fibres encased by a myelin sheath, located anterior to the lamina cribrosa [1]. First described by Virchow in 1856, a myelinated retinal nerve fibre layer (RNFL) appears as a whitish, feathery patch...

Graham Popham joins Glaukos as Senior Director, Market Access EMEAI

Glaukos are delighted to announce the appointment of Graham Popham as Senior Director, Market Access EMEAI. Graham comments: "’I'm excited to join Glaukos at such a pivotal time in the evolution of ophthalmic care and growth of the organisation. Throughout...

Fight for Sight to maximise impact by funding solutions-focused research in priority eye conditions

Fight for Sight aims to stop sight loss by funding pioneering research. Rod McNeil takes a look at the Primer Fellowship Awards programme, which provides funding for up to £60,000 for individuals to undertake vision-related research for one year. Among...

VISION 2020 LINKS Programme: Reviewing the first ten years and announcing the new diabetic retinopathy initiative

The VISION 2020 LINKS Programme celebrates its 10th anniversary next month. Over the past decade it has achieved its objective of building capacity for eye care in developing countries, particularly in Africa, by establishing long-term training partnerships between institutions, known...

Capsular tension rings to reduce refractive shift

The study group aimed to determine whether the use of a capsular tension ring (CTR) can increase refractive stability in patients with implantation of two different trifocal intraocular lenses. This was a prospective, consecutive series of eyes which underwent refractive...

Measuring patient-reported outcomes after refractive surgery to assess patient satisfaction

Patient-reported outcomes enable surgeons to evaluate patients’ symptoms and satisfaction after laser vision correction. The great majority of patients are pleased with their outcomes from laser vision correction, whether it is with photorefractive keratectomy, laser in-situ keratomileusis (LASIK), or small...

Midland Eye performs its first Presserflo Microshunt to treat Glaucoma

Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.

Understanding medical negligence in the UK: a brief overview

Medical negligence, or clinical negligence, refers to a breach of duty of care by healthcare professionals that results in harm or injury to a patient. In the UK, medical negligence is a serious issue that can have profound consequences for...

Aflibercept for the treatment of neovascular glaucoma

The aim of this study was to investigate initial results regarding the treatment of neovascular glaucoma (NVG) with intravitreal aflibercept. NVG is classified into stages 0-3. In stages 1 and 2, abnormal vessel proliferation is seen with or without elevated...